YDYasufumi Doi

Yasufumi Doi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yasufumi Doi has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Toshiharu Ninomiya

    Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    12 shared publications
  • Yutaka Kiyohara

    Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    12 shared publications
  • Jun Hata

    Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    9 shared publications
  • Masanori Iwase

    Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    9 shared publications
  • Mitsuo Iida

    Kyushu University

    8 shared publications
  • Koji Yonemoto

    From the Departments of Medicine and Clinical Science (Y.D., T.N., J.H., M.F., M. Iwase, M. Iida) and Environmental Medicine (Y.D., T.N., J.H., M.F., K.Y., Y.K.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    7 shared publications

Latest Publications

  • Open Access

    Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study

    by Atsuko Sekita, Hisatomi Arima, Toshiharu Ninomiya, Tomoyuki Ohara, Yasufumi Doi, Yoichiro Hirakawa, Masayo Fukuhara, Jun Hata, Koji Yonemoto, Yukiko Ga, et al.

    Background: Uncertainty still surrounds the association between metabolic syndrome (MetS) and depression. We aimed to evaluate the association between MetS and elevated depressive symptoms in a general Japanese population.Methods: This is a cross-sectional survey of 3,113 community-dwelling individuals aged 40 years or over. MetS was defined according to the joint interim statement. MetS was diagnosed when a subject had three or more of the following components: 1) central obesity (waist circumference ≥90 cm for men, ≥80 cm in for women); 2) elevated blood pressure (≥130/85 mmHg or current use of antihypertensive medication); 3) hypertriglyceridemia (≥1.7 mmol/L); 4) low HDL cholesterol (< 1.0 mmol/L for men, < 1.3 mmol/L for women); and 5) elevated fasting plasma glucose (≥5.55 mmol/L or current use of antidiabetic medication). Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The age- and multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI) were estimated using a logistic regression model.Results: Elevated depressive symptoms were observed in 4.3% of male and 6.3% of female participants. In men, the age-adjusted prevalence of elevated depressive symptoms was significantly higher in subjects with MetS than in those without (7.1% versus 3.6%, p = 0.04). The prevalence of elevated depressive symptoms rose progressively as the number of MetS components increased (3.5%, 3.6%, 5.8%, and 9.2% in male subjects with 0–1, 2, 3, and ≥4 components, respectively; p = 0.02 for trend). This association remained significant even after adjustment for age, marital status, history of cardiovascular disease, smoking habit, alcohol intake, and regular exercise. In women, on the other hand, there was no clear association between MetS and depressive symptoms.Conclusions: MetS was associated with elevated depressive symptoms in a general population of Japanese men.


  • Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study

    by A. Hata, Y. Doi, T. Ninomiya, N. Mukai, Y. Hirakawa, J. Hata, M. Ozawa, K. Uchida, T. Shirota, T. Kitazono, et al.

    Aims: Early studies have shown that magnesium intake decreases the risk of Type 2 diabetes, but the results are still inconsistent. We prospectively examined the association between magnesium intake and incidence of Type 2 diabetes in a general Japanese population.Methods: A total of 1999 subjects without diabetes aged 40–79 years who underwent a 75‐g oral glucose tolerance test were followed up prospectively for a mean of 15.6 years.Results: During the follow‐up, 417 subjects developed Type 2 diabetes. The age‐ and sex‐adjusted incidence of Type 2 diabetes significantly decreased with increasing magnesium intake quartile levels (≤ 148.5, 148.6–171.5, 171.6–195.5 and ≥ 195.6 mg/day, P for trend = 0.01). In multivariate analyses, after adjusting for comprehensive risk factors and other dietary factors, the hazard ratio of Type 2 diabetes was 0.67 (95% CI 0.49–0.92; P = 0.01) in the third quartile and 0.63 (95% CI 0.44–0.90; P = 0.01) in the highest quartile compared with the first quartile. In addition, the risk of Type 2 diabetes was 14% lower (P = 0.04) for a 1‐sd increment of log‐transformed magnesium intake in the multivariate‐adjusted model. In stratified analysis, there were statistically significant interactions between magnesium intake and levels of homeostasis model assessment of insulin resistance, high‐sensitivity C‐reactive protein or alcohol intake on the risk of Type 2 diabetes (all P < 0.05).Conclusions: Our findings suggest that increased magnesium intake was a significant protective factor for the incidence of Type 2 diabetes in the general Japanese population, especially among subjects with insulin resistance, low‐grade inflammation and a drinking habit.


  • Open Access

    Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study

    by Fumie Ikeda, Yasufumi Doi, Toshiharu Ninomiya, Yoichiro Hirakawa, Naoko Mukai, Jun Hata, Kentaro Shikata, Daigo Yoshida, Takayuki Matsumoto, Takanari Kitazono, et al.

    There is little information about predictive ability of haemoglobin A1c (HbA1c) for cardiovascular disease (CVD) in Asians. To investigate the discriminatory ability of HbA1c to identify subjects who are at greater risk of developing CVD in a prospective study of a defined community-dwelling Japanese population.


  • Open Access

    Angiopoietin-Like Protein 2 and Risk of Type 2 Diabetes in a General Japanese Population

    by Yasufumi Doi, Toshiharu Ninomiya, Yoichiro Hirakawa, Otowa Takahashi, Naoko Mukai, Jun Hata, Masanori Iwase, Takanari Kitazono, Yuichi Oike, Yutaka Kiyohara

    OBJECTIVE To examine, for the first time, the association between a novel inflammatory cytokine, angiopoietin-like protein (ANGPTL) 2, and the development of type 2 diabetes (T2DM). RESEARCH DESIGN AND METHODS A total of 2,164 community-dwelling Japanese individuals aged 40 to 79 years without diabetes were followed up for 7 years. Serum ANGPTL2 levels were divided into quartile categories at baseline: P = 0.01). CONCLUSIONS Elevated serum ANGPTL2 levels were positively associated with the development of T2DM in a general population, independent of other risk factors including hs-CRP levels.


  • Open Access

    Insulin Resistance and the Development of Cardiovascular Disease in a Japanese Community: the Hisayama Study

    by Seiji Gotoh, Yasufumi Doi, Jun Hata, Toshiharu Ninomiya, Naoko Mukai, Masayo Fukuhara, Masahiro Kamouchi, Takanari Kitazono, Yutaka Kiyohara

    Aims: Although several surrogate measures of insulin resistance have been proposed, their associations with cardiovascular disease (CVD) have not been evaluated sufficiently. Methods: A total of 2,356 community-dwelling Japanese individuals aged 40 to 79 years who underwent a 75 g oral glucose tolerance test were followed up for 14 years. The status of insulin resistance was estimated by using the Matsuda index or homeostasis model assessment of insulin resistance (HOMA-IR). Results: During follow-up, 260 subjects developed CVD. The age- and sex-adjusted hazard ratios of CVD significantly decreased with an increasing Matsuda index and rose with increasing HOMA-IR levels (both p for trend <0.05). After adjustment for age, sex, serum total cholesterol, electrocardiogram abnormalities, proteinuria, smoking habits, alcohol intake, and regular exercise, the risk of CVD was significantly lower in the third to fifth quintiles of the Matsuda index and higher in the fifth quintile of HOMA-IR values compared with the first quintile of the corresponding index (Matsuda index Q3: hazard ratio (HR)= 0.59 [95% confidence interval 0.40-0.87]; Q4: HR= 0.66 [0.45-0.97]; and Q5: HR= 0.67 [0.47-0.97]; HOMA-IR Q5: HR= 1.55 [1.05-2.29]); however, these associations were attenuated after further adjustment for the metabolic syndrome status. In regard to CVD subtypes, the risks for stroke and coronary heart disease significantly decreased with an increasing Matsuda index, while elevated HOMA-IR levels were a significant risk factor for stroke, but not for coronary heart disease. Conclusion: Our findings suggest that insulin resistance significantly increases the risk of incident CVD through metabolic syndrome in Japanese.


  • Two risk score models for predicting incident Type 2 diabetes in Japan

    by Y. Doi, T. Ninomiya, J. Hata, Y. Hirakawa, N. Mukai, M. Iwase, Y. Kiyohara

    Diabet. Med. 29, 107–114 (2012) Aims  Risk scoring methods are effective for identifying persons at high risk of Type 2 diabetes mellitus, but such approaches have not yet been established in Japan.Methods  A total of 1935 subjects of a derivation cohort were followed up for 14 years from 1988 and 1147 subjects of a validation cohort independent of the derivation cohort were followed up for 5 years from 2002. Risk scores were estimated based on the coefficients (β) of Cox proportional hazards model in the derivation cohort and were verified in the validation cohort.Results  In the derivation cohort, the non‐invasive risk model was established using significant risk factors; namely, age, sex, family history of diabetes, abdominal circumference, body mass index, hypertension, regular exercise and current smoking. We also created another scoring risk model by adding fasting plasma glucose levels to the non‐invasive model (plus‐fasting plasma glucose model). The area under the curve of the non‐invasive model was 0.700 and it increased significantly to 0.772 (P < 0.001) in the plus‐fasting plasma glucose model. The ability of the non‐invasive model to predict Type 2 diabetes was comparable with that of impaired glucose tolerance, and the plus‐fasting plasma glucose model was superior to it. The cumulative incidence of Type 2 diabetes was significantly increased with elevating quintiles of the sum scores of both models in the validation cohort (P for trend < 0.001).Conclusions  We developed two practical risk score models for easily identifying individuals at high risk of incident Type 2 diabetes without an oral glucose tolerance test in the Japanese population.


  • N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community

    by Yasufumi Doi, Toshiharu Ninomiya, Jun Hata, Yoichiro Hirakawa, Naoko Mukai, Fumie Ikeda, Masayo Fukuhara, Masanori Iwase, Yutaka Kiyohara

    Objective—: Few studies have examined the association between natriuretic peptides and the incidence of cardiovascular disease (CVD) in Asian populations. Methods and Results—: A total of 3104 community-dwelling Japanese individuals aged ≥40 years without history of CVD were followed up for 5 years. A total of 127 CVD events were identified. The age- and sex-adjusted incidence of CVD increased with increasing N-terminal pro-brain natriuretic peptide (NT-proBNP) levels (P =0.03; 125–399 pg/mL: 2.98 [95% CI 1.65–5.39], P P P =0.006) increased by adding NT-proBNP values to the model including other potential risk factors. Conclusion—: Elevated NT-proBNP levels were shown to be a significant risk factor for the development of CVD and its subtypes in a general Japanese population, independently of other cardiovascular risk factors.


  • Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study

    by Masashi Miyazaki, Yasufumi Doi, Fumie Ikeda, Toshiharu Ninomiya, Jun Hata, Kazuhiro Uchida, Tomoko Shirota, Takayuki Matsumoto, Mitsuo Iida, Yutaka Kiyohara

    The results of prospective studies examining the association between dietary vitamin A intake and the risk of gastric cancer have often been conflicting. The objective of this study was to investigate this issue in a general Japanese population. A total of 2,467 community-dwelling Japanese subjects aged 40 years or older were followed up prospectively for 14 years. Dietary vitamin A intake was estimated using a semiquantitative food frequency method. During the follow-up period, gastric cancer developed in 93 subjects. The age- and sex-adjusted incidence of gastric cancer rose progressively with increasing levels of dietary vitamin A intake: at 2.2, 3.0, 3.8, and 4.5 per 1,000 person-years for quartile groups defined by dietary vitamin A intake levels of 1,061 μg retinol equivalents (RE)/day, respectively (P for trend 1,061 μg RE/day) and Helicobacter pylori infection. Our findings suggest that dietary vitamin A intake is clearly associated with the risk of gastric cancer in the general Japanese population.


  • Cut‐off values of fasting and post‐load plasma glucose and HbA1c for predicting Type 2 diabetes in community‐dwelling Japanese subjects: the Hisayama Study

    by N. Mukai, Y. Doi, T. Ninomiya, J. Hata, Y. Hirakawa, M. Fukuhara, M. Iwase, Y. Kiyohara

    Diabet. Med. 29, 99–106 (2012) Aims  We examined the optimal cut‐off values of fasting plasma glucose, 2‐h post‐load glucose and HbA1c for predicting Type 2 diabetes in community‐dwelling Japanese subjects.Methods  A total of 1982 subjects without diabetes aged 40–79 years who underwent a 75‐g oral glucose tolerance test were followed prospectively for 14 years by annual health examination.Results  During the follow‐up, 295 subjects developed Type 2 diabetes. Compared with the first decile, the crude hazard ratio for incident Type 2 diabetes was significantly higher in the fifth fasting plasma glucose decile [5.4–5.4 mmol/l (97–98 mg/dl)] or higher, in the seventh 2‐h post‐load glucose decile [6.9–7.2 mmol/l (124–131 mg/dl)] or higher, and in the fifth HbA1c decile [34–36 mmol/mol (5.3–5.4%)] or higher. These associations remained substantially unchanged even after adjustment for confounding factors. The receiver operating characteristic curve analysis showed that the optimal cut‐off values for predicting Type 2 diabetes were 5.6 mmol/l (101 mg/dl) for fasting plasma glucose, 6.9 mmol/l (124 mg/dl) for 2‐h post‐load glucose and 37 mmol/mol (5.5%) for HbA1c. In a stratified analysis, the cut‐off values were approximately 5.6 mmol/l (101 mg/dl) for fasting plasma glucose and 37 mmol/mol (5.5%) for HbA1c, and these values were unchanged over BMI quartile levels, whereas the 2‐h post‐load glucose cut‐off values declined with decreasing BMI levels.Conclusions  Our findings suggest that the cut‐off value for predicting Type 2 diabetes in the Japanese population is 5.6 mmol/l (101 mg/dl) for fasting plasma glucose and 37 mmol/mol (5.5%) for HbA1c, while the 2‐h post‐load glucose cut‐off value is lower than the diagnostic criterion for impaired glucose tolerance.